Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
Fiche publication
Date publication
février 2020
Journal
Cancer medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LACOUR Brigitte
Tous les auteurs :
Butel T, Karanian M, Pierron G, Orbach D, Ranchere D, Cozic N, Galmiche L, Coulomb A, Corradini N, Lacour B, Proust S, Guerin F, Boutroux H, Rome A, Mansuy L, Vérité C, Defachelles AS, Tirode F, Minard-Colin V
Lien Pubmed
Résumé
Rhabdomyosarcoma (RMS) in infants is a particular entity with various clinical presentations and outcomes. To better understand the clinical heterogeneity of RMS in infants, an integrative clinical, histological, and molecular analysis was performed.
Mots clés
VGLL2, infants, newborns, rhabdoid tumor, rhabdomyosarcoma, spindle cell rhabdomyosarcoma
Référence
Cancer Med. 2020 Feb 22;: